European Archives - Page 62 of 1531 - European Medical Journal

EMJ

IL-1 in Focus: An Expert Question and Answer Session

Sobi has launched a four-part podcast series featuring leading experts in rheumatology, exploring the role of IL-1 in…

HIV Progress Uneven Across Middle East and North Africa

HIV cases continue to rise across the Middle East and North Africa despite progress in prevention and treatment, with stigma and inequality limiting care access for LGBTQIA+ communities.

RAAS Inhibitors Lower Liver Cancer Risk in MASLD - EMJ

RAAS Inhibitors in MASLD Linked to Lower Liver Cancer Risk

RAAS inhibitor use in MASLD is linked to lower hepatocellular carcinoma risk in a large Taiwan cohort. Find out more from the study findings.

Subtraction CT improves extravasation detection - EMJ

Subtraction CT Boosts Extravasation Detection in Pelvic Fractures

Subtraction CT improved extravasation detection and shortened reading times in patients with pelvic fractures.

Treatment of High-Burden AD Areas

Atopic dermatitis (AD) affecting the head and neck, hands, and genitals is associated with a high burden of impact on quality of…

EuroPCR 2026 Interview: Thomas Cuisset

I think it’s actually quite difficult to describe precisely how the meeting has evolved in recent years, but what has remained absolutely…

AI Medical Imaging Market Growth Accelerates - EMJ

AI medical imaging market set for rapid growth

The global AI medical imaging market is projected to grow rapidly as healthcare systems adopt AI tools to improve diagnostics and reduce radiologist workload.

Type 2 Diabetes Subtypes Linked to Mortality Risk Differences

Type 2 diabetes subtypes show differing mortality risks in South Asian cohorts. Insulin-deficient forms carry higher risk. Read more.

ESCMID 2026 Interview: Daniel Pan

I think the most important thing this award recognises is the nature of the award itself. It brings together young scientists from across…

EuroPCR 2026: AI Boosts Confidence in OCT-Guided PCI Decisions

AI-assisted OCT support improved clinician confidence during PCI decision-making and eliminated differences between experienced and less experienced OCT users at EuroPCR 2026.